Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

24
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
24
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

50
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
50
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

863
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
863
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

74
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
74

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Panvascular Changes Under Intensive Medical Therapy in Intracranial Atherosclerotic Steno-Occlusive Disease.

Journal of the American Heart Association·2026
Same author

Structural MRI Volumetry Index for Differentiation of Progressive Supranuclear Palsy From Parkinson's Disease and Multiple System Atrophy by Automatic Segmentation: A Comparison With Magnetic Resonance Parkinsonism Index.

Journal of magnetic resonance imaging : JMRI·2026
Same author

RAPSN/rapsyn aggregation-induced HSPA/HSP70-BAG3 aggrephagy maintains CHRN integrity in myasthenia gravis.

Autophagy·2026
Same author

Long-term safety and continued clinical benefit of erenumab 70 mg in Asian patients with chronic migraine: an open-label extension of the phase 3 DRAGON study.

The journal of headache and pain·2026
Same author

Deep white matter injury and cognitive decline in cerebral small vessel disease: Mediation by a unified atrophy network.

Journal of Alzheimer's disease : JAD·2026
Same author

A reverse genetics-based NS1-truncated live attenuated vaccine confers broad heterologous protection against swine influenza viruses.

Microbial pathogenesis·2026

関連する実験動画

Updated: Sep 8, 2025

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

25.7K

血管収縮と脳卒中再発 濃縮性脂質低下療法による頭蓋内動脈硬化症

Weizhuang Yuan1, Zhongrui Yan2, Baoquan Lu3

  • 1Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases (W.Y., X.H., Caiyan Liu, Y.X., W.-H.X.), Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing.

Stroke
|August 20, 2025
PubMed
まとめ
この要約は機械生成です。

濃度の脂質低下療法により,頭蓋内動脈硬化狭窄症の外壁の限界変化を引き起こす可能性があります. この境界線の縮小は,再発性脳卒中のリスクを大幅に増加させ,その臨床的重要性を強調します.

キーワード:
動脈硬化症収縮,病理的な発血性脳卒中プラーク,動脈硬化再発する

さらに関連する動画

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.1K
Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery
09:41

Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery

Published on: December 23, 2014

16.6K

関連する実験動画

Last Updated: Sep 8, 2025

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

25.7K
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.1K
Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery
09:41

Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery

Published on: December 23, 2014

16.6K

科学分野:

  • 神経学
  • 心血管医学
  • 放射線科

背景:

  • 頭蓋内動脈硬化症 (ICAS) は,不全性脳卒中の重大なリスクをもたらします.
  • 血管壁のダイナミックな変化,特に血管の外壁の境界は,濃度の脂質低下療法では十分に理解されていません.
  • これらの変化を理解することは,治療の有効性を評価し,ICAS患者の臨床結果を予測するために不可欠です.

研究 の 目的:

  • 脂質低下療法を受けているICAS患者における外壁境界領域の動的変化を調査する.
  • 外壁の境界面の変化と再発性脳卒中のリスクとの関連を評価する.

主な方法:

  • 多センターコホート研究では,ICASによる急性性性脳卒中の患者137人が,高用量スタチンとPCSK9阻害剤を投与された.
  • 高解像度3DT1重量MRI血管壁画像は,開始時点と6ヵ月以上のフォローアップ後に実施されました.
  • 外壁の境界面の変化は膨張,収縮,または静止として分類され,再発性脳卒中との関連はKaplan-MeierとCoxの回帰モデルを使用して分析された.

主要な成果:

  • 137人の患者のうち36. 5%が外壁境界の膨張,29. 2%が収縮,34. 3%が静止を示した.
  • すべてのグループでプラークの負荷が著しく低下し,膨張と静止のグループでは光の面積が増加したが,縮小のグループではそうではなかった.
  • 外壁の境界領域の縮小は,再発性イプシラテラル脳卒中 (HR,2. 95; P=0. 046) のリスク増加と有意に関連しており,この関連性は多変量調整 (HR,4. 21; P=0. 031) 後に持続した.

結論:

  • 脂質低下療法を受けているICAS患者では,外壁の境界領域の動態は著しく変化します.
  • 外壁の限界領域の縮小は脳卒中再発のリスクを予測する重要なイメージングバイオマーカーです.
  • これらの発見は,ICASにおけるリスクの階層化とパーソナライズされた治療戦略のための外壁境界の変化の監視の重要性を強調しています.